Tissue Banking Market Research Report By Application (Regenerative Medicine, Drug Discovery, Tissue Engineering, Transplantation), By Type of Tissue Bank (Cell Bank, Organ Bank, Tissue Bank), By Storage Method (Cryopreservation, Lyophilization, Chemical Preservation), By End Use (Hospitals, Research Institutions, Pharmaceutical Companies) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa)- Forecast to 2035

Tissue Banking Market Overview

As per MRFR analysis, the Tissue Banking Market Size was estimated at 4.3 (USD Billion) in 2023.The Tissue Banking Market Industry is expected to grow from 4.53(USD Billion) in 2024 to 8 (USD Billion) by 2035. The Tissue Banking Market CAGR (growth rate) is expected to be around 5.3% during the forecast period (2025 - 2035)

Key Tissue Banking Market Trends Highlighted

Various industry trends are driving the expansion of the Global Tissue Banking industry. Key market drivers include the rising need for organ transplantation caused by the increase in chronic illnesses and the growing knowledge of the advantages of tissue banking. Tissue banks have also been driven to broaden their services and capacities by the necessity for regenerative medicine and biomedical research, so guaranteeing a consistent supply of human tissues for therapeutic and research objectives. Recent trends have shown an increase in partnerships between research institutions and tissue banks, hence improving the creation and use of tissue-based products.

Furthermore, automated procedures and better preservation methods, among other technological developments, are helping to make tissue collecting and storage more dependable and efficient. Opportunities in the Global Tissue Banking Market include the possibility of creating personalized pharmaceutical solutions and growing into developing countries where healthcare infrastructure is changing. Tissue banks are looking into collaborations with biotech companies to produce fresh tissue-engineering applications that might use stored tissue capabilities. Recent developments also imply an emphasis on regulatory compliance and quality control to assure the safety and efficacy of the tissues gathered, complying with standards from health authorities.

Moreover, since older people frequently need more medical treatments, including organ transplants, the aging population worldwide is projected to increase the need for more comprehensive tissue banking services. These advances will set the global tissue banking market for ongoing change, providing notable opportunities for invention and expansion in the years to come.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Tissue Banking Market Drivers

Rising Demand for Organs and Tissues for Transplants

Driven by the growing need for organ and tissue transplants, the Global Tissue Banking Market is expanding significantly. According to the Global Observatory on Donation and Transplantation, roughly 140,000 organs were transplanted worldwide last year, which indicates a steady increase caused by the aging population and the rising incidence of chronic illnesses such as diabetes and cardiovascular diseases. To raise transplant success rates, organizations such as the World Health Organization (WHO) are vigorously supporting tissue banking programs.

This increasing need for transplantable tissues is anticipated to propel a notable rise in both supply and research efforts, thereby greatly affecting the development dynamics of the Global Tissue Banking Market Industry.

Advancements in Research and Development

A key driver for the Global Tissue Banking Market Industry is the improvement in Research and Development (R) capabilities connected to enhanced treatments and regenerative medicine. Governments and organizations worldwide are progressively funding R projects emphasizing tissue engineering and cell treatments. Over the last several years, for example, the National Institutes of Health (NIH) have set aside more than $1 billion for regenerative medicine research.

As the need for high-quality tissue samples rises for both academic and commercial uses, this financing is vital for creating creative tissue banking technologies and standards, which will probably drive the industry forward.

Increased Awareness and Participation in Biobanking

Awareness of biobanking procedures and the function of tissue banks in aiding scientific research is rising. Projects run by groups like the Biobank and Biomolecular Resources Research Infrastructure help the public understand how biobanking enables studies that finally result in medicinal innovations. Valued at over $55 billion last year, the Global Biobanking Market is expected to expand as more people participate in tissue donation and banking efforts.

As more stakeholders see its relevance, this trend especially encourages investments and operational expansion in the Global Tissue Banking Market Industry.

Tissue Banking Market Segment Insights

Tissue Banking Market Application Insights

The Global Tissue Banking Market is experiencing substantial growth, particularly within its Application segment, which plays a crucial role in various medical fields. In 2024, this market is expected to generate a revenue of 4.53 USD Billion, reflecting the increasing need for tissue samples in clinical research and applications. By 2035, the market is projected to grow to 8.0 USD Billion, driven by advancements in technology and demand for personalized medicine. The Application segment is composed of key areas including Regenerative Medicine, Drug Discovery, Tissue Engineering, and Transplantation, each contributing significantly to the overall market dynamics.

Regenerative Medicine holds a majority share with a valuation of 1.6 USD Billion in 2024, increasing to 2.8 USD Billion by 2035. The importance of this area lies in its potential to develop innovative therapies that can heal or replace damaged tissues and organs, making it a cornerstone for the future of healthcare. Drug Discovery, valued at 1.0 USD Billion in 2024 and anticipated to reach 1.8 USD Billion by 2035, is critical for developing new medications and treatments. Tissue samples are essential in this process as they provide invaluable data for testing drug efficacy and safety, which drives pharmaceutical advancements.

The Tissue Engineering application, with a market valuation of 1.3 USD Billion in 2024 and expected to grow to 2.2 USD Billion by 2035, focuses on producing artificial organs and tissues. This sector not only alleviates donor shortages but also enhances transplant safety. Meanwhile, the Transplantation area, valued at 0.63 USD Billion in 2024 and rising to 1.2 USD Billion by 2035, is vital for treating patients with organ failure, underlining the importance of tissue preservation and banking for effective transplant outcomes. Overall, the Global Tissue Banking Market segmentation indicates a diverse landscape wherein each application plays a central role in supporting healthcare advancements, enhancing treatment options, and improving patient outcomes.Growth in these applications is driven by rising disease prevalence, increasing investment in Research and Development (R), and a growing emphasis on personalized medicine, thus creating ample opportunities for innovation and collaboration within the industry.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Tissue Banking Market Type of Tissue Bank Insights

The Global Tissue Banking Market is a dynamic sector within the healthcare industry, projected to reach a valuation of 4.53 Billion USD in 2024, with marked growth expected in subsequent years. This market encompasses various types of tissue banks, including Cell Banks, Organ Banks, and Tissue Banks, each playing a crucial role in regenerative medicine and transplantation. Cell Banks are vital for storing stem cells and other biological cells that can be used for Research and Development, therapeutics, and advanced therapies.

Organ Banks, on the other hand, are significant as they facilitate the recovery and transplantation of organs, addressing critical shortages in transplantable tissues. Tissue Banks contribute to the preservation and provision of various human tissues for surgical and medical uses, making them indispensable in modern medicine. This segment is experiencing growth due to an increasing demand for biopharmaceuticals, advancements in technology, and the rising prevalence of chronic diseases globally. Despite challenges such as regulatory hurdles and ethical considerations, the Global Tissue Banking Market continues to expand, driven by innovations and increasing collaborations across the industry, reflecting a robust market growth outlook.

Tissue Banking Market Storage Method Insights

The Global Tissue Banking Market is witnessing significant growth, particularly within the Storage Method segment, which plays a crucial role in preserving biological materials. By 2024, the market is expected to be valued at 4.53 USD Billion, highlighting the increasing demand for effective storage solutions. Among the various methods employed, Cryopreservation stands out for its ability to preserve vital tissues at ultra-low temperatures, ensuring cellular integrity for extended periods. Lyophilization, or freeze-drying, has gained traction due to its efficiency in reducing storage volume while maintaining the viability of biological samples.

Meanwhile, Chemical Preservation is essential for extending the lifespan of tissues by utilizing specific chemicals to prevent degradation. As the Global Tissue Banking Market evolves, these storage methods not only enhance the viability of samples but also support advancements in Research and Development, ultimately meeting the growing needs of the healthcare and biotechnology sectors. The convergence of improved technologies and regulatory support further paves the way for innovations in the tissue banking landscape. Thus, the importance of effective storage methods cannot be overstated, as they are fundamental to the success of tissue preservation efforts globally.

Tissue Banking Market End Use Insights

The Global Tissue Banking Market is poised for substantial growth, driven largely by increased demand across various end-use categories, notably Hospitals, Research Institutions, and Pharmaceutical Companies. As of 2024, the market is set to reach a valuation of 4.53 USD Billion, reflecting the growing importance of tissue banks in both clinical and research settings. Hospitals play a critical role, as they utilize stored tissues for patient care and recovery, thereby enabling advancements in transplantology. Research Institutions are vital for progress in medical science, employing tissue samples for innovative studies that enhance our understanding of diseases.

Meanwhile, Pharmaceutical Companies leverage tissue banking for drug development and validation processes, ensuring therapies are safe and effective. Together, these sectors demonstrate significant synergy, contributing to the overall market dynamics. The growth in this industry is further supported by trends such as technological advancements in biobanking processes, regulatory support for tissue use, and rising investment in biotechnology, providing extensive opportunities for innovation and market expansion. The Global Tissue Banking Market revenue is expected to reflect these trends, showcasing promising statistics across the end-use landscape.

Tissue Banking Market Regional Insights

The Global Tissue Banking Market demonstrates considerable growth, particularly within the regional segment. North America holds the majority, with a valuation of 2.0 USD Billion in 2024, expected to rise to 3.5 USD Billion by 2035, dominating due to advanced healthcare infrastructure and high Research and Development investments. Following, Europe is valued at 1.2 USD Billion in 2024, projected to reach 2.0 USD Billion by 2035, driven by stringent regulatory frameworks that enhance quality and safety in tissue banking. APAC, representing a growing opportunity, stands at 0.8 USD Billion in 2024, increasing to 1.4 USD Billion by 2035 as emerging economies invest more in healthcare technologies.

South America, though smaller, sees growth from 0.3 USD Billion in 2024 to 0.6 USD Billion in 2035, attributed to increasing healthcare access. Lastly, the MEA region, beginning at 0.23 USD Billion in 2024 and growing to 0.5 USD Billion by 2035, benefits from governmental initiatives aimed at enhancing healthcare systems. Collectively, these regions showcase significant potential within the Global Tissue Banking Market revenue and illustrate strategic health investments that respond to growing demand and technological advancements in tissue preservation and research.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Tissue Banking Market Key Players and Competitive Insights

The competitive landscape of the Global Tissue Banking Market is characterized by a dynamic interplay of various players, ranging from large multinational corporations to specialized niche firms. The industry has seen significant advancements in technology, regulatory frameworks, and an increasing demand for tissue-based therapies, driven by rising applications in regenerative medicine and personalized treatments. Companies operating in this market strive to differentiate themselves through innovation, quality of products, and strategic partnerships.

Furthermore, the increasing focus on research and development, coupled with collaborative efforts for biobanking and ethical sourcing of tissues, has shaped a competitive arena that is both challenging and ripe with opportunities. Lonza holds a prominent position in the Global Tissue Banking Market, leveraging its extensive experience in cell and gene therapy applications and providing comprehensive solutions for researchers and practitioners. The company's strength lies in its commitment to quality and its ability to offer a wide range of cellular products that cater to the evolving needs of the market. Lonza has a strong market presence due to its advanced infrastructure, state-of-the-art facilities, and a solid supply chain, ensuring reliability and efficiency in tissue procurement.

Additionally, the firm has invested strategically in collaborations and partnerships that enhance its product offerings, thereby securing a competitive edge in the global landscape. The combination of technological expertise and a robust operational framework enables Lonza to maintain its leadership position within the industry.Tissue Regenix has carved a niche in the Global Tissue Banking Market by focusing on the development and commercialization of regenerative medical products, particularly in the area of tissue repair and replacement solutions. The company’s key products include decellularized tissues that are designed for various surgical applications, providing innovative solutions to meet clinical needs.

Tissue Regenix's strengths lie in its proprietary technology platforms, which allow for the safe and effective processing of human and animal tissues, thus enhancing usability and patient outcomes. The company's strategic focus on expanding its market presence through international collaborations, mergers, and acquisitions has further bolstered its position. Its tactical alignment with healthcare providers and research institutions underscores its commitment to advancing regenerative medicine on a global scale, fostering growth and innovation in the tissue banking sector.

Key Companies in the Tissue Banking Market Include

• Lonza


• Tissue Regenix


• Corning


• Roche Holding


• Thermo Fisher Scientific


• CytoSource


• Charles River Laboratories


• MilliporeSigma


• BioreclamationIVT


• Organogenesis


• Stemcell Technologies


• AllCells


• Asterand Bioscience


• PerkinElmer


• Reprocell

Tissue Banking Market Industry Developments

The Global Tissue Banking Market is currently experiencing significant developments, reflecting both technological advancements and growth prospects. Companies like Lonza, Tissue Regenix, Corning, Roche Holding, and Thermo Fisher Scientific are key players highlighting their continued investment in Research and Development to enhance tissue preservation techniques. In July 2023, Corning announced improvements in its cell culture products, potentially impacting tissue bank operations positively. Current market dynamics have shown an upward trend in biological samples demand, driven by advancements in regenerative medicine and personalized healthcare.

Furthermore, there have been discussions around potential mergers and acquisitions, with significant focus on Charles River Laboratories acquiring a smaller biotech firm in June 2023 to expand its portfolio in biobanking solutions. On the product front, companies such as Stemcell Technologies and BioreclamationIVT are introducing enhanced cryopreservation technologies which are shaping industry standards. Overall, the tissue banking sector is witnessing heightened collaboration among institutions, focusing on ethical sourcing and regulatory compliance amidst shifting market needs and increasing global healthcare demands, suggesting a positive trajectory for market growth.

Tissue Banking Market Segmentation Insights

Tissue Banking Market Application Outlook

• Regenerative Medicine


• Drug Discovery


• Tissue Engineering


• Transplantation

Tissue Banking Market Type of Tissue Bank Outlook

• Cell Bank


• Organ Bank

Tissue Bank

Tissue Banking Market Storage Method Outlook

• Cryopreservation


• Lyophilization


• Chemical Preservation

Tissue Banking Market End Use Outlook

• Hospitals


• Research Institutions

Pharmaceutical Companies

Tissue Banking Market Regional Outlook

• North America


• Europe


• South America


• Asia Pacific


• Middle East and Africa

 

Report Attribute/Metric Source:	Details
MARKET SIZE 2023	4.3(USD Billion)
MARKET SIZE 2024	4.53(USD Billion)
MARKET SIZE 2035	8.0(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR)	5.3% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
MARKET FORECAST PERIOD	2025 - 2035
HISTORICAL DATA	2019 - 2024
MARKET FORECAST UNITS	USD Billion
KEY COMPANIES PROFILED	Lonza, Tissue Regenix, Corning, Roche Holding, Thermo Fisher Scientific, CytoSource, Charles River Laboratories, MilliporeSigma, BioreclamationIVT, Organogenesis, Stemcell Technologies, AllCells, Asterand Bioscience, PerkinElmer, Reprocell
SEGMENTS COVERED	Application, Type of Tissue Bank, Storage Method, End Use, Regional
KEY MARKET OPPORTUNITIES	Increasing demand for regenerative medicine, Technological advancements in storage systems, Growing investment in biobanks, Rising prevalence of chronic diseases, Expanding applications in research and diagnostics
KEY MARKET DYNAMICS	increasing demand for transplants, advancements in preservation technologies, stringent regulatory frameworks, growing research activities, rising investment in biobanking
COUNTRIES COVERED	North America, Europe, APAC, South America, MEA